Article
Immunogenicity of DNA vaccine encoding spike protein against Middle East respiratory syndrome coronavirus in mammalian model
2024-01-30
Abstract excerpt
<title>Abstract</title> <p>Background: The Middle East respiratory syndrome coronavirus (MERS-CoV) is currently a major threat to public health worldwide. There are, as of yet, no licensed MERS-CoV vaccines or therapeutics. The rapid development and deployment of low-cost and effective vaccines against emerging variants has renewed interest in DNA vaccine technology. So, the aim of the current study is the gener...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0fa8885d-e481-5c71-99bb-c26ca28ba92f
- DOI
- 10.21203/rs.3.rs-3890698/v1
